Pascal Druzgala

602 total citations
24 papers, 456 citations indexed

About

Pascal Druzgala is a scholar working on Cardiology and Cardiovascular Medicine, Oncology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Pascal Druzgala has authored 24 papers receiving a total of 456 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Cardiology and Cardiovascular Medicine, 5 papers in Oncology and 5 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Pascal Druzgala's work include Estrogen and related hormone effects (4 papers), Cardiac electrophysiology and arrhythmias (4 papers) and Gastrointestinal motility and disorders (3 papers). Pascal Druzgala is often cited by papers focused on Estrogen and related hormone effects (4 papers), Cardiac electrophysiology and arrhythmias (4 papers) and Gastrointestinal motility and disorders (3 papers). Pascal Druzgala collaborates with scholars based in United States, Canada and Germany. Pascal Druzgala's co-authors include Nicholas Bodor, Günther Hochhaus, Whei‐Mei Wu, Alan R. Zinsmeister, Duane D. Burton, Michael Camilleri, María I. Vázquez‐Roque, Thomas J. Ford, Sanna McKinzie and M.J. Pekka Raatikainen and has published in prestigious journals such as Circulation, Gastroenterology and Journal of Controlled Release.

In The Last Decade

Pascal Druzgala

24 papers receiving 428 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pascal Druzgala United States 11 106 82 67 66 61 24 456
Kazushi Sakurai Japan 10 130 1.2× 64 0.8× 22 0.3× 38 0.6× 63 1.0× 18 520
C Zekorn Germany 8 94 0.9× 50 0.6× 18 0.3× 15 0.2× 14 0.2× 10 510
Danilo Wegner Germany 12 120 1.1× 25 0.3× 3 0.0× 27 0.4× 16 0.3× 19 582
Anil Pareek India 12 45 0.4× 2 0.0× 31 0.5× 56 0.8× 48 0.8× 29 443
André Farkouh Austria 8 62 0.6× 3 0.0× 81 1.2× 107 1.6× 18 0.3× 17 394
Jiecan Zhou China 10 145 1.4× 10 0.1× 8 0.1× 9 0.1× 45 0.7× 34 442
Mohammad Irfan Khan India 8 60 0.6× 5 0.1× 126 1.9× 31 0.5× 6 0.1× 72 381
Paresh P. Chothe United States 14 178 1.7× 5 0.1× 19 0.3× 20 0.3× 5 0.1× 34 571
J. Moppert Switzerland 11 76 0.7× 8 0.1× 3 0.0× 19 0.3× 14 0.2× 25 472
Xiaojiao Li China 15 138 1.3× 6 0.1× 3 0.0× 18 0.3× 40 0.7× 65 696

Countries citing papers authored by Pascal Druzgala

Since Specialization
Citations

This map shows the geographic impact of Pascal Druzgala's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pascal Druzgala with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pascal Druzgala more than expected).

Fields of papers citing papers by Pascal Druzgala

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pascal Druzgala. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pascal Druzgala. The network helps show where Pascal Druzgala may publish in the future.

Co-authorship network of co-authors of Pascal Druzgala

This figure shows the co-authorship network connecting the top 25 collaborators of Pascal Druzgala. A scholar is included among the top collaborators of Pascal Druzgala based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pascal Druzgala. Pascal Druzgala is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Albrecht, Detlef, David Ellis, Daniel M. Canafax, et al.. (2017). Pharmacokinetics and pharmacodynamics of tecarfarin, a novel vitamin K antagonist oral anticoagulant. Thrombosis and Haemostasis. 117(4). 706–717. 9 indexed citations
2.
Bowersox, S. Scott, et al.. (2011). Metabolism and Pharmacokinetics of Naronapride (ATI-7505), a Serotonin 5-HT4 Receptor Agonist for Gastrointestinal Motility Disorders. Drug Metabolism and Disposition. 39(7). 1170–1180. 9 indexed citations
3.
Bowersox, S. Scott, Daniel M. Canafax, Pascal Druzgala, Peter Milner, & Jeffrey I. Weitz. (2010). Antithrombotic Activity of the Novel Oral Anticoagulant, Tecarfarin [Sodium 3-[4-((1,1,1,3,3,3-hexafluoro-2-methylpropan-2-yloxy) carbonyl) benzyl]-2-oxo-2H-chromen-4-olate] in Animal Models. Thrombosis Research. 126(5). e383–e388. 10 indexed citations
4.
Choppin, Agnès, Ian Irwin, Lei Shao, et al.. (2009). Effect of tecarfarin, a novel vitamin K epoxide reductase inhibitor, on coagulation in beagle dogs. British Journal of Pharmacology. 158(6). 1536–1547. 17 indexed citations
5.
Camilleri, Michael, María I. Vázquez‐Roque, Duane D. Burton, et al.. (2006). Pharmacodynamic effects of a novel prokinetic 5‐HT4 receptor agonist, ATI‐7505, in humans. Neurogastroenterology & Motility. 19(1). 30–38. 79 indexed citations
6.
Morey, Timothy E., Christoph N. Seubert, M.J. Pekka Raatikainen, et al.. (2001). Structure-Activity Relationships and Electrophysiological Effects of Short-Acting Amiodarone Homologs in Guinea Pig Isolated Heart. Journal of Pharmacology and Experimental Therapeutics. 297(1). 260–266. 19 indexed citations
7.
Raatikainen, M.J. Pekka, Timothy E. Morey, Pascal Druzgala, et al.. (2000). Potent and Reversible Effects of ATI-2001 on Atrial and Atrioventricular Nodal Electrophysiological Properties in Guinea Pig Isolated Perfused Heart. Journal of Pharmacology and Experimental Therapeutics. 295(2). 779–785. 8 indexed citations
8.
Rachwał, Stanisław, Pascal Druzgala, Zhenzhen Liu, et al.. (1998). Full length article. Steroids. 63(4). 193–201. 4 indexed citations
9.
Schreier, Hans, Lucie Gagné, Thomas Bock, et al.. (1997). Physicochemical properties and in vitro toxicity of cationic liposome cDNA complexes. Pharmaceutica Acta Helvetiae. 72(4). 215–223. 36 indexed citations
10.
Raatikainen, M.J. Pekka, Carlo Napolitano, Pascal Druzgala, & Donn M. Dennis. (1996). Electrophysiological effects of a novel, short-acting and potent ester derivative of amiodarone, ATI-2001, in guinea pig isolated heart.. Journal of Pharmacology and Experimental Therapeutics. 277(3). 1454–1463. 18 indexed citations
11.
Brewster, Marcus E., Pascal Druzgala, Wesley R. Anderson, et al.. (1995). Efficacy of a 3‐Substituted Versus 17‐Substituted Chemical Delivery System for Estradiol Brain Targeting. Journal of Pharmaceutical Sciences. 84(1). 38–43. 5 indexed citations
12.
Brewster, Marcus E., et al.. (1994). Effect of Molecular Manipulation on the Estrogenic Activity of a Brain-Targeting Estradiol Chemical Delivery System. Journal of Medicinal Chemistry. 37(24). 4237–4244. 15 indexed citations
13.
Hochhaus, Günther, Pascal Druzgala, John F. Howes, Nicholas Bodor, & Hartmut Derendorf. (1994). Response to the Commentary on “Pharmacokinetic Characterization and Tissue Distribution of the New Glucocorticoid Soft Drug Loteprednol Etabonate in Rats and Dogs”. Journal of Pharmaceutical Sciences. 83(7). 1067–1068. 1 indexed citations
14.
Brewster, Marcus E., et al.. (1993). The Effect of Dihydronicotinate N-Substitution on the Brain-Targeting Efficacy of a Zidovudine Chemical Delivery System. Pharmaceutical Research. 10(9). 1356–1362. 15 indexed citations
15.
Hochhaus, Günther, Anna Ratka, Pascal Druzgala, et al.. (1992). Pharmacokinetic Characterization and Tissue Distribution of the New Glucocorticoid Soft Drug Loteprednol Etabonate in Rats and Dogs. Journal of Pharmaceutical Sciences. 81(12). 1210–1215. 30 indexed citations
16.
Druzgala, Pascal, et al.. (1992). New Water-Soluble Pilocarpine Derivatives with Enhanced and Sustained Muscarinic Activity. Pharmaceutical Research. 9(3). 372–377. 13 indexed citations
17.
Druzgala, Pascal, Günther Hochhaus, & Nicholas Bodor. (1991). Soft drugs—10. Blanching activity and receptor binding affinity of a new type of glucocorticoid: Loteprednol etabonate. The Journal of Steroid Biochemistry and Molecular Biology. 38(2). 149–154. 74 indexed citations
18.
Druzgala, Pascal, et al.. (1991). Ocular absorption and distribution of loteprednol etabonate, a soft steroid, in rabbit eyes. Current Eye Research. 10(10). 933–937. 70 indexed citations
19.
20.
Sidwell, R. W., et al.. (1991). Improved Delivery through Biological Membranes. Synthesis and Antiviral Activity of a Series of Ribavirin Chemical Delivery Systems: 2′ and 3′ Derivatives. Antiviral chemistry & chemotherapy. 2(6). 337–355. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kazushi Sakurai Breakdown of academic impact, for papers by C Zekorn Breakdown of academic impact, for papers by Danilo Wegner Breakdown of academic impact, for papers by Anil Pareek Breakdown of academic impact, for papers by André Farkouh Breakdown of academic impact, for papers by Jiecan Zhou Breakdown of academic impact, for papers by Mohammad Irfan Khan Breakdown of academic impact, for papers by Paresh P. Chothe Breakdown of academic impact, for papers by J. Moppert Breakdown of academic impact, for papers by Xiaojiao Li
Rankless by CCL
2026